DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

Clinical trial NCT05770037 · RECRUITING

Trial details

NCT number: NCT05770037
Sponsor: Cancer Research UK
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Haematological Malignancy Malignant Neoplasm Lymphoproliferative Disorders Neoplasms by Histologic Type Neoplasms by Site Cancer Anaplastic Large Cell Lymphoma Lymphoma Renal Cell Carcinoma Neuroblastoma Solid Tumour

Start date: 2023-12-18
Primary completion: 2029-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.